scispace - formally typeset
Search or ask a question
Institution

Mahidol University

EducationBangkok, Nakhon Pathom, Thailand
About: Mahidol University is a education organization based out in Bangkok, Nakhon Pathom, Thailand. It is known for research contribution in the topics: Population & Malaria. The organization has 23758 authors who have published 39761 publications receiving 878781 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: Local injection with botulinum toxin serotypes A and B into major salivary glands is most effective to reduce drooling.

166 citations

Journal ArticleDOI
TL;DR: Francois Nosten and colleagues evaluate malaria prevalence and incidence in the mobile population on the Myanmar side of the border with Thailand between 1999 and 2011 and also assess resistance to artemisinin.
Abstract: Background The Shoklo Malaria Research Unit has been working on the Thai–Myanmar border for 25 y providing early diagnosis and treatment (EDT) of malaria. Transmission of Plasmodium falciparum has declined, but resistance to artesunate has emerged. We expanded malaria activities through EDT and evaluated the impact over a 12-y period. Methods and Findings Between 1 October 1999 and 30 September 2011, the Shoklo Malaria Research Unit increased the number of cross-border (Myanmar side) health facilities from two to 11 and recorded the number of malaria consultations. Changes in malaria incidence were estimated from a cohort of pregnant women, and prevalence from cross-sectional surveys. In vivo and in vitro antimalarial drug efficacy were monitored. Over this period, the number of malaria cases detected increased initially, but then declined rapidly. In children under 5 y, the percentage of consultations due to malaria declined from 78% (95% CI 76–80) (1,048/1,344 consultations) to 7% (95% CI 6.2–7.1) (767/11,542 consultations), p<0.001. The ratio of P. falciparum/P. vivax declined from 1.4 (95% CI 1.3–1.4) to 0.7 (95% CI 0.7–0.8). The case fatality rate was low (39/75,126; 0.05% [95% CI 0.04–0.07]). The incidence of malaria declined from 1.1 to 0.1 episodes per pregnant women-year. The cumulative proportion of P. falciparum decreased significantly from 24.3% (95% CI 21.0–28.0) (143/588 pregnant women) to 3.4% (95% CI 2.8–4.3) (76/2,207 pregnant women), p<0.001. The in vivo efficacy of mefloquine-artesunate declined steadily, with a sharp drop in 2011 (day-42 PCR-adjusted cure rate 42% [95% CI 20–62]). The proportion of patients still slide positive for malaria at day 3 rose from 0% in 2000 to reach 28% (95% CI 13–45) (8/29 patients) in 2011. Conclusions Despite the emergence of resistance to artesunate in P. falciparum, the strategy of EDT with artemisinin-based combination treatments has been associated with a reduction in malaria in the migrant population living on the Thai–Myanmar border. Although limited by its observational nature, this study provides useful data on malaria burden in a strategically crucial geographical area. Alternative fixed combination treatments are needed urgently to replace the failing first-line regimen of mefloquine and artesunate. Please see later in the article for the Editors' Summary

166 citations

Journal ArticleDOI
TL;DR: It is found that dengue virus not only uses preexisting enhancing antibodies to promote its entry into Fc receptor-bearing cells but also exploits enhancing antibodies for intracellular immune evasion through 2 mechanisms, which are mediated by the suppressive cytokine interleukin 10 and high levels of IL-10.
Abstract: We have found that dengue virus (DENV) not only uses preexisting enhancing antibodies to promote its entry into Fc receptor-bearing cells but also exploits enhancing antibodies for intracellular immune evasion through 2 mechanisms. In the first mechanism, entry of DENV-antibody complexes into human monocytic cells activates negative regulators, dihydroxyacetone kinase and autophagy-related 5-autophagy-related 12, which then disrupt the retinoic acide incucible gene I and melanoma differentiation associated gene 5 signaling cascade and disable type 1 interferon production, leading to suppression of interferon-mediated antiviral responses. In the second mechanism, the immune evasion was found to be mediated by the suppressive cytokine interleukin 10 (IL-10). High levels of IL-10 activated expression of suppressor of cytokine signaling 3 gene, which subsequently inactivated the Janus kinase-signal transducer and activator of transcription pathway. Inhibition of IL-10 production by small interfering RNA down-regulated suppressor of cytokine signaling 3 gene expression, restored inducible nitric oxide synthase gene expression, and suppressed DENV replication. Importantly, we were able to demonstrate that these 2 loops of suppression occurred in patients with severe secondary dengue infection (dengue hemorrhagic fever) but not in patients with mild secondary dengue infection (dengue fever).

166 citations

Journal ArticleDOI
TL;DR: In this paper, two extensions to the three-dimensional magnetotelluric inversion program WSINV3DMT are described, including modifications to allow inversion of the vertical magnetic transfer functions (VTFs), and parallelization of the code.

166 citations

Journal ArticleDOI
TL;DR: The mechanisms involved in chemoresistance of breast CSCs are complex and not clearly defined, and innovative therapies, based on a better understanding of C SCs, should lead to enhanced and long-term cure rates in breast cancer.
Abstract: Cancer stem cells (CSCs) have recently been documented in solid tumours. Evidence has sug- gested that CSCs are involved in carcinogenesis, tumour invasion and metastases, and resis- tance to various forms of therapies, including chemotherapy. Breast CSCs are characterised by the expression of CD44 but lack of CD24 (CD44 þ /CD24 � cells). The mechanisms involved in chemoresistance of breast CSCs are complex and not clearly defined. Overexpression of ABC transporters, detoxification enzymes (aldehyde dehydrogenase), low cell turn over rate and the ability to activate the DNA check point response are possibly all involved. Innovative therapies, based on a better understanding of CSCs, should lead to enhanced and long-term cure rates in breast cancer.

166 citations


Authors

Showing all 23819 results

NameH-indexPapersCitations
Nicholas J. White1611352104539
Pete Smith1562464138819
Randal J. Kaufman14049179527
Kevin Marsh12856755356
Barry M. Trost124163579501
John R. Perfect11957352325
Jon Clardy11698356617
François Nosten11477750823
Paul Turner114109961390
Paul Kubes10939341022
Ian M. Adcock10766042380
Peter H. Verburg10746434254
Guozhong Cao10469441625
Carol L. Shields102142446800
Nicholas P. J. Day10270850588
Network Information
Related Institutions (5)
University of Hong Kong
99.1K papers, 3.2M citations

86% related

University of Maryland, Baltimore
64.7K papers, 2.9M citations

86% related

University of Alabama at Birmingham
86.7K papers, 3.9M citations

86% related

Case Western Reserve University
106.5K papers, 5M citations

86% related

University of Pittsburgh
201K papers, 9.6M citations

85% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202329
2022187
20213,386
20203,028
20192,630
20182,531